Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
US6906049B1 · kind B1 · utility
7Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 1999 |
| Grant date | Jun 14, 2005 |
| Priority date | — |
| Expiry date | Oct 25, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/811
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the field of chemistry and more particularly to that of therapeutic chemistry.The invention relates more particularly to novel contraceptive compositions formed from a progestative agent and an oestrogen.The invention relates specifically to novel pharmaceutical contraceptive compositions, characterized in that they contain, as active ingredients, a nomegestrol ester and oestradiol, in combination or admixture with an inert, non-toxic, pharmaceutically-acceptable vehicle or diluent which is suitable for oral administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.